Invitation to presentation of Thor Medical ASA's second half and full year results 2024

20 Feb 2025 08:00 CET

20.2.2025 08:00:00 CET | Thor Medical ASA | Non-regulatory press releases

Thor Medical ASA will release its second half and full year results 2024 on
Wednesday 26 February 2025 at 07:00 am (CEST). A presentation of the results
followed by a Q&A session will be held on the same day at 08:00 am at Carnegie's
offices at Aker Brygge, Fjordalleen 16, and through a live webcast. The
presentation and the Q&A session can be followed through a live webcast from our
website www.thormedical.com - https://www.thormedical.no or using the following
link: Thor Medical Webcast 2H 2024 -
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20250226_1.

CONTACTS

* Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18428720/5649/Download%20announce
ment%20as%20PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

639229_Download announcement as PDF.pdf